1. Applying for a Cartel Leniency Marker
When a company discovers potential price-fixing, market allocation, or bid-rigging within its operations, timing can become critical. A marker from the Antitrust Division of the U.S. Department of Justice holds the applicant’s place in line for a limited period while counsel investigates the conduct.
Obtaining a marker does not itself provide final immunity. The company must continue through the DOJ Leniency Program and satisfy the applicable requirements for leniency.
Why Marker Priority Matters
The Leniency Program generally provides corporate leniency to the first qualifying applicant for the reported antitrust conspiracy. A delay can therefore create substantial risk if another participant approaches the Antitrust Division first.
The marker period gives counsel an opportunity to interview relevant personnel, examine transactional and communication records, and determine the scope of the potentially unlawful conduct. These findings can then be used to provide the additional information required by the Antitrust Division.
2. Perfecting the Marker and Preserving Evidence
After the Antitrust Division grants a marker, the applicant must provide sufficient information within the period specified by the Division to perfect it. Counsel will generally need to develop facts concerning the nature of the cartel, affected products or services, relevant individuals, geographic scope, and duration of the conduct.
Incomplete factual disclosure, delayed cooperation, or failure to terminate participation in the unlawful activity can affect eligibility for leniency.
Internal Investigation and Document Retention
Evidence preservation is an important part of this process. Corporate leadership and counsel should identify potentially relevant electronic records, pricing information, communications, meeting materials, and other documents before information is deleted or altered through ordinary business practices.
A coordinated government and internal investigation can help determine what occurred while allowing counsel to manage privilege and disclosure issues throughout the review.
Relevant materials may include server backups, corporate emails, encrypted messaging records, meeting minutes, executive calendars, pricing documentation, and communications with other suspected participants. Counsel should also determine which domestic or foreign entities were involved and establish the geographic and temporal scope of the reported activity.
3. Cooperation after a Leniency Application
Conditional leniency does not end the applicant’s responsibilities. The company must continue providing timely, truthful, complete, and continuing cooperation as required by the Antitrust Division.
Continuing Disclosure and Employee Cooperation
Cooperation may involve producing documents, responding to government requests, identifying relevant individuals, and making qualifying personnel available for interviews, testimony, or other investigative steps.
Additional facts may emerge as the company’s internal review progresses. Material information concerning the cartel should be addressed as part of the applicant’s continuing cooperation with the Antitrust Division. A failure to satisfy applicable cooperation requirements can jeopardize conditional leniency and potentially expose the organization to prosecution under federal antitrust law.
The company should therefore maintain a coordinated process for gathering information and communicating with prosecutors rather than treating the initial marker request as the end of the leniency process.
4. Cross-Border Marker Strategy and Private Civil Exposure
International cartels can create exposure in several jurisdictions at the same time. A marker obtained from the U.S. Antitrust Division does not automatically provide leniency from competition authorities outside the United States.
Coordinating Leniency Across Jurisdictions
Where conduct affects multiple markets, counsel should determine whether separate marker or leniency applications may be appropriate in other jurisdictions. Each competition authority can apply its own eligibility, priority, and cooperation requirements, making the timing of parallel applications particularly important.
A coordinated approach can reduce the risk that a company preserves its position in the United States but loses an opportunity for leniency elsewhere.
Managing Follow-on Civil Claims
Federal criminal leniency also does not eliminate every form of civil exposure. Private plaintiffs may pursue follow-on antitrust claims after cartel conduct becomes known.
Under the Antitrust Criminal Penalty Enhancement and Reform Act, qualifying leniency applicants that provide the required cooperation to civil claimants may receive limitations on damages that would otherwise be available under federal antitrust law. The requirements for this protection should be evaluated separately from the criminal leniency application.
Potential follow-on civil litigation should therefore be considered when counsel develops the company’s broader leniency strategy, particularly where the alleged conduct affected a substantial number of customers or transactions.
5. Faq
What happens if another cartel participant applies for leniency first?
The DOJ Leniency Program generally reserves corporate leniency for the first qualifying applicant for the reported conspiracy that satisfies the program’s requirements. If another participant establishes priority first, a later applicant ordinarily cannot obtain leniency for the same conduct through the program, although cooperation may still be relevant to how the government resolves the matter.
Does a DOJ leniency marker protect corporate officers from prosecution?
A marker alone should not be treated as an automatic grant of immunity to individual directors, officers, or employees. Individual protection depends on the applicable Corporate Leniency Policy, the terms of any conditional leniency letter, and satisfaction of relevant cooperation requirements. Counsel should therefore evaluate corporate and individual exposure separately as the application proceeds.
26 Aug, 2026
